Results 151 to 160 of about 75,166 (219)

Safety, tolerability, and immunogenicity of SPVX02, a room temperature-stabilised tetanus-diphtheria vaccine, compared to two established tetanus-diphtheria booster vaccines: a multicentre, single-blind, randomised, first-in-human phase 1 trial in the UK. [PDF]

open access: yesEClinicalMedicine
Reed TAN   +18 more
europepmc   +1 more source

Specific IgG levels before and one month after administration of a booster dose of the diphtheria, tetanus, and pertussis vaccine in 14-year-old adolescents. [PDF]

open access: yesFront Immunol
Kostinov M   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy